Overview

Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
0
Participant gender:
Female
Summary
This study aims to test the effect of Doxycycline in treatment of uterine bleeding during the use of injectable contraception that contains one hormone "progesterone only".
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Omar Mamdouh Shaaban
Treatments:
Doxycycline
Medroxyprogesterone
Medroxyprogesterone Acetate
Criteria
Inclusion Criteria:

1. Women under DMPA contraception for at least one month.

2. Accept to participate in the trial after receiving adequate information about the
trial including information that she is a part of randomization comprising the
possibility of receiving new treatment for bleeding or inactive ingredients.

3. Women's ability to keep an accurate menstrual diary for the study.

Exclusion Criteria:

1. Lactating women for the fear of the effect of tetracycline on the breast-fed infant.

2. Patients with already diagnosed local gynecological abnormality.

3. Women receiving treatment for bleeding within the last one month.